FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884902804> ?p ?o ?g. }

• W2884902804 endingPage "175883591878233" @default.
• W2884902804 startingPage "175883591878233" @default.
• W2884902804 abstract "In the intensity-modulated radiotherapy (IMRT) era, the survival benefit of concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains undetermined. This study aimed to evaluate the benefits of IMRT with concurrent chemotherapy compared with IMRT alone for LA-NPC patients with different plasma Epstein-Barr virus (EBV) DNA levels.Patients were identified from a prospectively maintained database in an endemic area between November 2002 and December 2013. Cox proportional hazards models, propensity score matching, and inverse probability weighting models were established for survival analysis. Stratification analysis was performed based on interaction effects analysis. Finally, sensitivity analysis was performed considering unmeasured confounders.A total of 1357 eligible patients were enrolled (median follow up 62.4 months; range 3.5-155.8 months). No significant survival differences were observed between groups in the entire cohort. Notably, a significant interaction effect was observed between treatment regimens and EBV DNA levels. In patients with high EBV DNA levels (>4000 copies/ml), all three models showed that IMRT with concurrent chemotherapy significantly improved overall survival [hazard ratio (HR) 2.521, 95% confidence interval (CI) 1.218-5.216], disease-free survival (HR 2.168, 95% CI 1.349-3.483), and distant metastasis-free survival (HR 2.331, 95% CI 1.194-4.551) compared with IMRT alone. No differences were found in patients with low EBV DNA levels. Sensitivity analysis confirmed the robustness of the results.In the IMRT era, concurrent chemotherapy treatment of LA-NPC patients with high EBV DNA levels is reasonable. However, the optimal regimen for LA-NPC patients with low EBV DNA levels needs further validation in randomized clinical trials." @default.
• W2884902804 created "2018-08-03" @default.
• W2884902804 creator A5009521293 @default.
• W2884902804 creator A5023349881 @default.
• W2884902804 creator A5025156587 @default.
• W2884902804 creator A5032614467 @default.
• W2884902804 creator A5037660489 @default.
• W2884902804 creator A5042578262 @default.
• W2884902804 creator A5045080979 @default.
• W2884902804 creator A5048052584 @default.
• W2884902804 creator A5053275663 @default.
• W2884902804 creator A5054444050 @default.
• W2884902804 creator A5063145199 @default.
• W2884902804 creator A5069686416 @default.
• W2884902804 creator A5071191068 @default.
• W2884902804 creator A5084047711 @default.
• W2884902804 creator A5086392545 @default.
• W2884902804 creator A5091457305 @default.
• W2884902804 date "2018-01-01" @default.
• W2884902804 modified "2023-09-30" @default.
• W2884902804 title "The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area" @default.
• W2884902804 cites W1580788756 @default.
• W2884902804 cites W1586634518 @default.
• W2884902804 cites W1699808413 @default.
• W2884902804 cites W1945275010 @default.
• W2884902804 cites W1979606037 @default.
• W2884902804 cites W1987103754 @default.
• W2884902804 cites W1987104299 @default.
• W2884902804 cites W2000038676 @default.
• W2884902804 cites W2000617239 @default.
• W2884902804 cites W2004293592 @default.
• W2884902804 cites W2012658469 @default.
• W2884902804 cites W2012906610 @default.
• W2884902804 cites W2014401523 @default.
• W2884902804 cites W2014799253 @default.
• W2884902804 cites W2017276054 @default.
• W2884902804 cites W2024847643 @default.
• W2884902804 cites W2034786146 @default.
• W2884902804 cites W2039256900 @default.
• W2884902804 cites W2052866186 @default.
• W2884902804 cites W2064844057 @default.
• W2884902804 cites W2077889430 @default.
• W2884902804 cites W2077919953 @default.
• W2884902804 cites W2078682598 @default.
• W2884902804 cites W2079525135 @default.
• W2884902804 cites W2093974625 @default.
• W2884902804 cites W2102310008 @default.
• W2884902804 cites W2103371988 @default.
• W2884902804 cites W2105955346 @default.
• W2884902804 cites W2111635289 @default.
• W2884902804 cites W2116713862 @default.
• W2884902804 cites W2117038381 @default.
• W2884902804 cites W2125919881 @default.
• W2884902804 cites W2132871252 @default.
• W2884902804 cites W2144825354 @default.
• W2884902804 cites W2148900467 @default.
• W2884902804 cites W2151645021 @default.
• W2884902804 cites W2158776902 @default.
• W2884902804 cites W2161043223 @default.
• W2884902804 cites W2161612574 @default.
• W2884902804 cites W2186378789 @default.
• W2884902804 cites W2193303607 @default.
• W2884902804 cites W2266578659 @default.
• W2884902804 cites W2470928691 @default.
• W2884902804 cites W2742681205 @default.
• W2884902804 cites W4210983491 @default.
• W2884902804 doi "https://doi.org/10.1177/1758835918782331" @default.
• W2884902804 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6055246" @default.
• W2884902804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30046357" @default.
• W2884902804 hasPublicationYear "2018" @default.
• W2884902804 type Work @default.
• W2884902804 sameAs 2884902804 @default.
• W2884902804 citedByCount "14" @default.
• W2884902804 countsByYear W28849028042019 @default.
• W2884902804 countsByYear W28849028042020 @default.
• W2884902804 countsByYear W28849028042021 @default.
• W2884902804 countsByYear W28849028042022 @default.
• W2884902804 countsByYear W28849028042023 @default.
• W2884902804 crossrefType "journal-article" @default.
• W2884902804 hasAuthorship W2884902804A5009521293 @default.
• W2884902804 hasAuthorship W2884902804A5023349881 @default.
• W2884902804 hasAuthorship W2884902804A5025156587 @default.
• W2884902804 hasAuthorship W2884902804A5032614467 @default.
• W2884902804 hasAuthorship W2884902804A5037660489 @default.
• W2884902804 hasAuthorship W2884902804A5042578262 @default.
• W2884902804 hasAuthorship W2884902804A5045080979 @default.
• W2884902804 hasAuthorship W2884902804A5048052584 @default.
• W2884902804 hasAuthorship W2884902804A5053275663 @default.
• W2884902804 hasAuthorship W2884902804A5054444050 @default.
• W2884902804 hasAuthorship W2884902804A5063145199 @default.
• W2884902804 hasAuthorship W2884902804A5069686416 @default.
• W2884902804 hasAuthorship W2884902804A5071191068 @default.
• W2884902804 hasAuthorship W2884902804A5084047711 @default.
• W2884902804 hasAuthorship W2884902804A5086392545 @default.
• W2884902804 hasAuthorship W2884902804A5091457305 @default.
• W2884902804 hasBestOaLocation W28849028041 @default.
• W2884902804 hasConcept C10515644 @default.
• W2884902804 hasConcept C126322002 @default.

• next